Clinical Trial Update: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized controlled trial evaluating intravenous immunoglobulin for necrotizing soft-tissue infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fournier Gangrene
• Gas Gangrene
• Necrotizing Fasciitis
• Necrotizing Soft Tissue Infection

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Anders Perner | Conditions: Necrotizing Soft Tissue Infection, Necrotizing Fasciitis | Phase 2 | Status: COMPLETED